 NEW YORK, Sept. 09, 2021 GLOBE NEWSWIRE -- Fortress Biotech, Inc. NASDAQ: FBIO Fortress, an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in three virtual investor conferences in September 2021. 